The rise of GLP-1 weight loss drugs is changing consumer eating habits, leading to lower snacking volumes and new preferences for portion-controlled, nutrient-dense foods. For food and beverage companies, understanding these shifts at the account level is essential. By leveraging key account intelligence, actionable key account insights, and comprehensive client insights, brands can i... https://www.indigrowth.com/weight-loss-pills-are-eating-snack-sales/